At API, we provide comprehensive support throughout the product lifecycle—from development and formulation to clinical and commercial manufacturing. Whether you’re bringing a pharmaceutical product, active ingredient or natural health product to market, we offer customized GMP-compliant solutions to support your journey.
A Commercialization Partner Who Understands Your Journey
As one of Canada’s leading not-for-profit life sciences commercialization organizations, we deliver faster, more cost-effective and highly flexible solutions—whether you’re advancing a pharmaceutical, biologic, natural health product, medical device, diagnostic or other health technology.
We have expertise across all services under one roof—giving you a seamless, end-to-end experience from discovery to commercialization. With in-house teams spanning discovery and development, quantitative solutions, regulatory guidance and clinical and commercialization manufacturing, we bring a holistic perspective to every step. This integrated approach ensures that each decision is informed by the full product lifecycle—aligning science, strategy and execution to accelerate your path to market.
Our CDMO Capabilities
At API, we provide comprehensive support—guiding you from early-stage development to scalable, market-ready manufacturing with confidence and efficiency. Whether you’re an academic researcher, drug developer or biotech company, we offer the expertise, infrastructure, licensing and industry network to move you seamlessly through the commercialization pathway.
Clinical Trial Material Production
We specialize in producing high-quality, small-batch products to support Phase I–III clinical trials. Our cGMP-compliant facilities and experienced team ensure that your materials meet the highest standards for safety, consistency and regulatory readiness. With flexible capacity and a track record of understanding of clinical requirements timelines, we help you move through trials efficiently and effectively.
Commercial Manufacturing
As your product progresses, we offer scalable solutions for commercial manufacturing. Our cGMP-compliant facilities are equipped to support mid- to large-scale production, with a focus on maintaining quality, compliance, and cost-efficiency. Whether you’re launching in Canada, the U.S., or global markets, we provide the infrastructure and regulatory expertise needed to support a successful commercial rollout.
Products Supported for CDMO Services
-
Topical Application Manufacturing
Topical formulations are applied directly to the skin, allowing for localized delivery of active ingredients.…
-
Oral Dosage Manufacturing
Whether your product is a small molecule or a natural health product, our facilities offer…
-
Sterile Fill Finish
From small-scale clinical batches to large-scale commercial production, our cGMP-compliant facilities are equipped to handle…
Active Ingredients
-
Small Molecule Manufacturing
Whether your product is a small molecule or a natural health product, our facilities offer…
-
Highly Potent Controlled Substances
Whether it’s highly concentrated active pharmaceutical ingredients (APIs), chemicals or naturally sourced controlled substances, our…
Meet Our Senior Leaders and Contacts
Launa Aspeslet
Chief Translational Officer
Read bioabout Launa Aspeslet Launa Aspeslet
Chief Translational Officer
Launa Aspeslet is an accomplished life science executive and board member with over 20 years of leadership experience in scaling early-stage organizations to sustainable growth and maturity. She excels in multi-stakeholder environments, new product development, and guiding entrepreneurs through organizational transformation.
Currently, Launa also serves as Senior Clinical & Regulatory Advisor to Model Medicines and a Board member of Edmonton Unlimited. She recently acted as interim CEO at Edmonton Unlimited and has held roles as COO at Hepion Pharmaceuticals, CEO of TRIO, and COO at Isotechnika Pharma. She has also provided strategic consulting for various early-stage drug and medical device companies. During this time, Launa has led teams to conduct over 50 clinical trials, enrolling more than 10,000 patients across 20 countries.
She holds a BSc in chemistry from the University of Lethbridge and a PhD in Pharmaceutical Sciences from the University of Alberta, along with a Regulatory Affairs Certification (RAC).
Allan Aginski
Senior VP, Special Projects & Manufacturing
Read bioabout Allan Aginski Allan Aginski
Senior VP, Special Projects & Manufacturing
Allan is a life sciences supply chain and manufacturing specialist with nearly 40 years of experience. He has established and run commercial life sciences company production facilities around the world, including for companies such as Abbott, Merck, and Genpharm. He has been responsible for the establishment of dozens of products in over 24 countries.
Hans Bauer
VP, Technical Operations
Read bioabout Hans Bauer Hans Bauer
VP, Technical Operations
Hans brings over 25 years of experience in pharmaceutical manufacturing and quality, having worked with leading pharmaceutical companies in Europe, including Lonza, Sandoz (Novartis), Acino, and Akorn. He has a proven track record in managing large teams, complex projects, and overseeing comprehensive operations.
Hans has strong expertise in developing and implementing robust quality systems that meet stringent regulatory standards across several countries, including the US, EU, and Switzerland. His production expertise includes API-small molecule manufacturing, peptide chemical and biotechnology manufacturing, as well as the production of solid and semi-solid forms and sterile manufacturing.
Shawn Couch
Director, Business Development
Read bioabout Shawn Couch Shawn Couch
Director, Business Development
Shawn Couch is a seasoned business development and key account management professional with over 20 years of experience in the North American pharmaceutical industry. With a strong track record of surpassing sales targets, he has expertise in drug substance and drug products, including solid oral, and injectables. His career includes business development roles at Corden Pharma, Fabricca Italiana Sintetici and ACIC Fine Chemicals, where he played a pivotal role in expanding market presence and increasing revenue.
Located in one of Canada’s Fastest-Growing Life Sciences Hubs
Located in Edmonton, Alberta, API sits at the heart of one of Canada’s fastest-growing life sciences ecosystems. Our region is experiencing a surge in investment, with new infrastructure, expanded research capacity, and a strong pipeline of talent. Anchored by globally recognized institutions like the University of Alberta, Life Sciences Campus at the Edmonton Research Park and surrounded by a growing community of startups and a tightknit entrepreneur community, Edmonton offers a uniquely collaborative environment for innovation.
Edmonton is also a key part of the Canadian Critical Drug Initiative (CCDI), a nearly $200 million project led by our team at API in partnership with the University of Alberta. Through the CCDI, we’re developing an integrated research, commercialization and manufacturing cluster within the Edmonton Metropolitan Region.
As a Canadian-based CDMO, we also offer cost advantages and access to international markets—making us an ideal partner for both domestic and global companies looking to scale their therapeutic innovations. The Canadian Critical Drug Initiative
API’s Manufacturing Facilities
Our state-of-the-art facilities are designed to support your drug development and manufacturing needs—from discovery to commercialization. These facilities offer a full suite of cGMP-compliant services, ensuring the highest standards of quality, safety and regulatory compliance across every stage of the product’s lifecycle.
Drug Development and Innovation Centre
Learn more![BBDC[3230]](https://appliedpharma.ca/wp-content/uploads/2025/05/BBDC3230-768x432.jpg)
Biotechnology Business Development Centre
Learn more
Critical Medicines Production Centre
Learn moreEnd-to-End Manufacturing Support
We provide comprehensive manufacturing solutions from preclinical stages to large-scale commercial production. Our integrated approach, combined with our Early Discovery & Development, Regulatory and Quantitative Solutions (QS) teams, ensures a seamless experience at every step of the development journey.
Discovery & Development
We create a seamless pathway from concept to commercialization, guiding your innovations through every stage of development.
Clinical & Quantitative Solutions
We specialize in guiding companies through preclinical, clinical, and market safety phases, providing expert support at every stage of development.
Regulatory & Quality
We bridge the gap between academia and industry by providing the full expertise, services, and infrastructure of a life sciences company.
Ready to take your life sciences innovation to the next level?
Contact us today for a free discovery consultation to determine how we can bring your idea to market together.
Get started